IV Ketamine vs. At-Home Ketamine: Safety and Trade-offs
At-home ketamine programs are convenient, but the FDA has warned about compounded ketamine used outside monitored settings. Here are the real trade-offs.
Two very different models of care
In-clinic IV ketamine means a scheduled appointment, an intravenous infusion given by clinicians, monitoring during and after the session, and a ride home with a responsible adult. At-home programs typically ship compounded ketamine — usually lozenges or tablets that dissolve in the mouth — for you to take where you live, often after a telehealth evaluation.
Both models exist legally in the United States, and both have grown quickly. They are not interchangeable, and the differences that matter most are about safeguards, not convenience.
What the FDA warning says
The FDA has warned patients and health care providers about potential risks associated with compounded ketamine products, particularly when they are used without adequate safeguards. Compounded products are not FDA-approved — a compounding pharmacy's version of a drug does not go through the FDA review that an approved medicine does — and the agency's warning highlights concerns about unsupervised use, dosing variability, and serious side effects occurring without medical support present.
That warning is the anchor for this whole comparison. It does not say at-home use is automatically unsafe in every case; it says the risks rise when screening, dosing, and monitoring are thin. Those are exactly the variables to investigate with any provider.
Convenience vs. monitoring: the real trade-off
The appeal of at-home treatment is genuine: no travel, lower logistical burden, and privacy. The cost of that convenience is that ketamine's acute effects — dissociation, dizziness, nausea, a temporary rise in blood pressure — happen without a clinician in the room. Most episodes are mild, but when a reaction is not mild, response time matters.
In a clinic, vital signs are watched, dosing is precise and adjustable during the session, and help is immediate if something goes wrong. Neither model removes risk entirely; they distribute it differently. Adults considering either should weigh that honestly rather than treating convenience as a small footnote.
Evidence differences worth knowing
Most of the controlled research behind ketamine for depression — including the randomized trials from 2006 and 2013 — studied intravenous dosing in monitored settings. Sublingual and oral forms are absorbed less predictably, and their evidence base is thinner. That does not mean they never help anyone; it means the strongest evidence and the at-home model are not the same thing, and marketing often blurs that line.
Questions to ask any provider — clinic or telehealth
Whichever model you are weighing, these questions will tell you most of what you need to know about how seriously a provider takes safety:
- Who performs the medical evaluation, and is it a real review of records and medications or a questionnaire?
- What monitoring happens during dosing, and who responds if I have a bad reaction?
- Is the product compounded, and if so, which pharmacy makes it and what quality standards does it follow?
- What is the plan for follow-up, and how do you coordinate with my existing doctors?
- What happens in an emergency — during a session and between sessions?
How we approach it
Clear Ketamine Therapy offers in-clinic, physician-supervised IV treatment precisely because monitoring is where we are not willing to compromise. If you are also considering an at-home program, we will discuss the trade-offs with you straight — including the convenience advantages — because an informed patient makes better decisions than a sold one.
If you ever feel unsafe during any treatment, anywhere, call 911. If you are in emotional crisis, call or text 988. Those resources matter more than any provider choice.
Common questions
Prescribing compounded ketamine for at-home use does occur, generally through telehealth. But compounded ketamine products are not FDA-approved, and the FDA has warned about potential risks — especially use without adequate safeguards. Legality and quality vary, so investigate the prescriber and the pharmacy carefully.
The FDA's safety communication describes potential risks of compounded ketamine products — including psychiatric and cardiovascular effects — particularly when used without monitoring. It notes the agency has received adverse event reports involving compounded ketamine. The full text is linked in our citations.
The honest answer is that nobody can promise comparable results. Oral and sublingual ketamine are absorbed less predictably than IV dosing, and most controlled trial evidence comes from IV studies in monitored settings. Treat claims of equivalence as unproven.
Ketamine can temporarily raise blood pressure and cause dissociation, nausea, or dizziness. In a clinic those effects are watched and managed in real time; at home they are handled by you and whoever is nearby. Rare but serious reactions are the reason monitoring exists at all.
Ask who evaluates you, what monitoring exists during dosing, which compounding pharmacy supplies the medicine, what the emergency plan is, and how follow-up is handled. Vague answers to any of these are a reason to pause.
Sources & further reading
- FDA warns patients and health care providers about potential risks associated with compounded ketamine products — U.S. Food and Drug Administration. Accessed 2026-07-23. The central safety communication for any clinic-vs-at-home comparison.
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial — American Journal of Psychiatry (via PubMed). Accessed 2026-07-23. Murrough et al., 2013 — illustrates that core trial evidence is IV-based and monitored.
- 988 Suicide & Crisis Lifeline — Substance Abuse and Mental Health Services Administration. Accessed 2026-07-23.
Links point to external organizations. Clear Ketamine Therapy does not control their content.
Keep reading
- IV Ketamine vs. SpravatoTwo different medicines, two different models of care. A factual comparison of IV ketamine and Spravato — approval status, evidence, and practical differences.
- Safety & Side EffectsThe full safety picture: common short-term side effects, who should not receive ketamine, the FDA's compounded-ketamine warning, and our monitoring practices.
- Ketamine Infusion TherapyWhat ketamine infusion therapy involves, how it differs from Spravato and at-home products, and why medical supervision matters.
Talk with our clinical team
A consultation is a conversation, not a commitment. Ask questions, share what you are comfortable sharing, and learn whether ketamine therapy may be worth considering for you.
Not for emergencies — call or text 988 or 911 if you are in crisis.